Comparison of the efficacy and tolerability of tigecycline and imipenem/cilastatin in patients with nosocomial pneumonia.

Trial Profile

Comparison of the efficacy and tolerability of tigecycline and imipenem/cilastatin in patients with nosocomial pneumonia.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jan 2011

At a glance

  • Drugs Imipenem/cilastatin; Tigecycline
  • Indications Nosocomial pneumonia; Staphylococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jan 2011 New trial record
    • 22 Jun 2009 Primary endpoint 'Clinical-response-rate' has not been met in the clinically-evaluable population but was met in the clinically-modified intention-to-treat population.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top